CARD17 Antikörper (AA 51-100)
Kurzübersicht für CARD17 Antikörper (AA 51-100) (ABIN6746959)
Target
Alle CARD17 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 51-100
-
Spezifität
- Human CARD17
-
Homologie
- Percent identity by BLAST analysis:
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa51-100 of human CARD17 (Q5XLA6, NP_001007233). Percent identity by BLAST analysis: Human, Monkey (100%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
-
Approved: WB (1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- CARD17 (Caspase Recruitment Domain Family, Member 17 (CARD17))
-
Andere Bezeichnung
- CARD17 / INCA
-
Hintergrund
-
Name/Gene ID: CARD17
Subfamily: Provisional protease
Family: Protease
Synonyms: CARD17, INCA, Inhibitory CARD, Caspase-1 inhibitor INCA -
Gen-ID
- 440068
-
NCBI Accession
- NP_001007233
Target
-